Standout Papers
Immediate Impact
2 by Nobel laureates 7 from Science/Nature 61 standout
Citing Papers
Trained immunity in chronic inflammatory diseases and cancer
2025 Standout
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Works of Maysa Abu‐Khalaf being referenced
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer
2018
A phase I/IB dose-escalation study of BEZ235 in combination with trastuzumab in patients with PI3-kinase or PTEN altered HER2+ metastatic breast cancer.
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Maysa Abu‐Khalaf | 962 | 602 | 301 | 343 | 90 | 1.8k | |
| Lola A. Fashoyin‐Aje | 990 | 315 | 415 | 272 | 65 | 1.7k | |
| Maria Carmela Piccirillo | 1185 | 400 | 760 | 486 | 92 | 2.2k | |
| Paul Smith | 1148 | 527 | 251 | 530 | 61 | 2.5k | |
| Valesca P. Retèl | 516 | 610 | 311 | 200 | 133 | 1.6k | |
| Ray D. Page | 952 | 540 | 807 | 420 | 79 | 2.0k | |
| Shenying Fang | 1069 | 333 | 326 | 473 | 68 | 1.9k | |
| Monika Klinkhammer‐Schalke | 1315 | 578 | 509 | 554 | 164 | 2.7k | |
| Erin Hofstatter | 791 | 596 | 241 | 484 | 60 | 1.8k | |
| Susan Dent | 1060 | 481 | 308 | 310 | 80 | 2.0k | |
| G. Pentheroudakis | 1256 | 371 | 395 | 489 | 33 | 2.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...